Stratos Health

Stratos Health operates at the intersection of employer-sponsored healthcare and advanced biomarker testing, offering AI-driven health optimization programs for organizations.

Reviewed by 7wData
Share Email

On this page

Profile

Provides employer-sponsored health plans with AI-powered biomarker testing and personalized wellness programs.

Stratos Health operates at the intersection of employer-sponsored healthcare and advanced biomarker testing, offering AI-driven health optimization programs for organizations. The company partners with Superpower to provide detailed biomarker analysis, linking blood panel results to chronic disease risk and aging. Its platform combines 24/7 telehealth, mental health support, and $0 copay prescriptions with data-driven lifestyle planning.

Stratos targets mid-market and enterprise employers through three branded programs: Baseline for general workforce health, Archa for executive wellness, and the upcoming A Vie major medical PPO launching in 2027. Financial backing comes from SEI Investments, which acquired a 57.5% stake in 2025, providing capital for the company's acquisition strategy - including 11 advisory practices totaling $4.8B in assets that year. Recent DOE funding restorations for carbon capture projects involving Stratos' namesake Texas facility (a separate JV with Occidental Petroleum and BlackRock) indicate broader corporate infrastructure but create potential brand confusion.

Track Stratos Health and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Mid-market employers seeking supplemental health benefits
  • Enterprise corporations with 1,000+ employees
  • Executive teams requiring concierge medical services
  • Self-insured organizations exploring alternative PPOs
  • Wealth management firms with health-focused client offerings

Strengths and what to watch

Strengths

  • SEI Investments' majority stake provides financial stability and wealth management channel access
  • Proprietary integration of biomarker testing with insurance products differentiates from traditional wellness programs
  • Three-tier product strategy (Baseline/Archa/A Vie) allows vertical segmentation from staff to C-suite

Watch for

  • Brand confusion with unrelated Occidental/BlackRock carbon capture facility sharing the Stratos name
  • Dependence on SEI's continued investment after 57.5% acquisition
  • Unproven adoption of A Vie major medical product ahead of 2027 launch

Recent moves

Key Information

Founded
2025

Frequently Asked Questions

What does Stratos Health do?

Stratos Health provides employer-sponsored health plans combining AI-powered biomarker testing with personalized wellness programs. Their platform integrates blood panel analysis, chronic disease risk assessment, telehealth, and mental health support. They serve mid-market to enterprise employers through tiered programs like Baseline for staff and Archa for executives.

How does Stratos Health use biomarker testing?

Stratos partners with Superpower to analyze employee biomarkers from blood tests, linking results to chronic disease risks and aging patterns. This data powers personalized wellness plans, differentiating their offering from traditional employer health programs. Testing is integrated with telehealth and $0 copay prescriptions.

Who owns Stratos Health?

SEI Investments acquired a 57.5% stake in Stratos Health in 2025, providing financial backing for acquisitions like 11 advisory practices totaling $4.8B in assets. This majority stake offers stability while enabling expansion through SEI's wealth management channels.

What types of companies use Stratos Health?

Stratos serves mid-market employers needing supplemental benefits and large corporations with 1,000+ employees. Their Archa program targets executives wanting concierge care, while Baseline covers general staff. Self-insured organizations and wealth managers also use their services. Product tiers allow vertical segmentation.

Is Stratos Health related to carbon capture projects?

No. A separate joint venture between Occidental Petroleum and BlackRock operates a carbon capture facility also named Stratos in Texas. This unrelated project sometimes causes brand confusion, though Stratos Health focuses solely on employer health programs and biomarker testing.

When will Stratos Health launch its major medical PPO?

Stratos plans to debut its A Vie major medical PPO product in 2027. This will expand their offerings beyond current wellness programs, though adoption remains unproven. The launch follows their 2025-2026 acquisition strategy and SEI investment.

Sources

  1. www.reuters.com — DOE funding restoration for carbon capture projects including Stratos Texas facility
  2. www.prnewswire.com — Acquisition of 11 practices and SEI's 57.5% stake
  3. www.stratoshealth.ai — Product offerings and Superpower partnership
  4. www.reuters.com — Existence of unrelated carbon capture facility sharing Stratos name